A Prospective Randomized Multicenter Study on the Impact of [

diagnostic imaging disease management fluorocholine prognosis prostate cancer

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
06 Jun 2024
Historique:
received: 03 01 2024
accepted: 07 05 2024
medline: 7 6 2024
pubmed: 7 6 2024
entrez: 6 6 2024
Statut: aheadofprint

Résumé

This study aimed to compare the efficacy of [

Identifiants

DOI: 10.2967/jnumed.123.267355 PMID: 38844361
pubmed: 38844361
pii: jnumed.123.267355
doi: 10.2967/jnumed.123.267355
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Laura Evangelista (L)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; laura.evangelista@hunimed.eu.
Nuclear Medicine Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.

Fabio Zattoni (F)

Urology Unit, Department of Surgery, Oncology, and Gastroenterology, Urologic Unit, University of Padua, Padua, Italy.
Department of Medicine, DIMED, University of Padua, Padua, Italy.

Marta Burei (M)

Nuclear Medicine Unit, Veneto Institute of Oncology, Padua, Italy.

Daniele Bertin (D)

Nuclear Medicine Unit, Veneto Institute of Oncology, Padua, Italy.

Eugenio Borsatti (E)

Nuclear Medicine Unit, Department of Radiation Oncology, Centro di Riferimento Oncologico, Aviano, Italy.

Tanja Baresic (T)

Nuclear Medicine Unit, Department of Radiation Oncology, Centro di Riferimento Oncologico, Aviano, Italy.

Mohsen Farsad (M)

Department of Nuclear Medicine, Central Hospital of Bolzano, Bozen, Italy.

Emanuela Trenti (E)

Department of Urology, Central Hospital of Bolzano, Bozen, Italy.

Mirco Bartolomei (M)

Nuclear Medicine Unit, University Hospital, Ferrara, Italy.

Stefano Panareo (S)

Nuclear Medicine Unit, University Hospital, Ferrara, Italy.
Nuclear Medicine Unit, Azienda Ospedaliero Universitaria di Modena, Modena, Italy.

Luca Urso (L)

Nuclear Medicine Unit, University Hospital, Ferrara, Italy.
Department of Environmental and Prevention Sciences, University of Ferrara, Ferrara, Italy.

Giuseppe Trifirò (G)

Nuclear Medicine Unit, ICS Maugeri IRCCS Spa SB, Pavia, Italy.

Elisabetta Brugola (E)

Nuclear Medicine Unit, ICS Maugeri IRCCS Spa SB, Pavia, Italy.

Franca Chierichetti (F)

Nuclear Medicine Unit, APSS della Provincia Autonoma di Trento, Santa Chiara Hospital, Trento, Italy.

Davide Donner (D)

Nuclear Medicine Unit, APSS della Provincia Autonoma di Trento, Santa Chiara Hospital, Trento, Italy.
Department of Medical and Surgical Sciences, Alma Mater Studiorum Università di Bologna, Bologna, Italy.

Lucia Setti (L)

Nuclear Medicine Unit, Humanitas Gavazzeni, Bergamo, Italy.

Mauro Gallan (M)

Nuclear Medicine Unit, Dell'Angelo Hospital, Mestre-Venezia, Italy; and.

Paola Del Bianco (P)

Clinical Research Unit, Veneto Institute of Oncology, Padua, Italy.

Giovanna Magni (G)

Clinical Research Unit, Veneto Institute of Oncology, Padua, Italy.

Gian Luca De Salvo (GL)

Clinical Research Unit, Veneto Institute of Oncology, Padua, Italy.

Giacomo Novara (G)

Urology Unit, Department of Surgery, Oncology, and Gastroenterology, Urologic Unit, University of Padua, Padua, Italy.

Classifications MeSH